Surgery Partners (SGRY) Preferred Stock Liabilities (2017 - 2021)

Surgery Partners' Preferred Stock Liabilities history runs 5 years deep, the most recent figure standing at $439.7 million for Q1 2021.

• In Q1 2021, Preferred Stock Liabilities rose 8.7% year-over-year to $439.7 million; the TTM figure through Mar 2021 stood at $439.7 million (up 8.7% YoY), while the FY2020 annual figure was $434.5 million, up 10.0% from the prior year.
• Preferred Stock Liabilities came in at $439.7 million for Q1 2021 at Surgery Partners, up from $434.5 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $439.7 million in Q1 2021 to a low of $330.8 million in Q4 2017.
• A 5-year average of $379.4 million and a median of $376.6 million in 2019 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities climbed 8.62% in 2018 and grew 10.0% in 2020, its largest moves.
• Surgery Partners' Preferred Stock Liabilities stood at $330.8 million in 2017, then gained by 8.62% to $359.3 million in 2018, then advanced by 9.94% to $395.0 million in 2019, then advanced by 10.0% to $434.5 million in 2020, then advanced by 1.2% to $439.7 million in 2021.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $439.7 million, $434.5 million, and $424.2 million for Q1 2021, Q4 2020, and Q3 2020 respectively.

Peer Comparison